This article is more than 5 years old. Information may no longer be current.

Yearly net income, revenues increase at Harrow Health

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Harrow Health reported a net income of $18.1 million and revenues of $11.4 million in the fourth quarter of 2018.

This compares with a net loss of $2.8 million and revenues of $7.3 million in 2017’s final quarter, according to a press release.

For the full year, the company, which includes the ophthalmology pharmaceutical compounding business ImprimisRx, had a net income of $14.6 million, or $0.67 per basic share, compared with a net loss of $12 million, or $0.60 per basic share, in 2017.

Total revenues increased from $26.8 million in 2017 to $41.4 million in 2018. Gross ophthalmology revenue increased 72% to $10 million.